Thursday, January 14, 2016
Experimental immunotherapy zaps two most lethal Ebola virus strains
The first antibodies that can potently neutralize the two deadliest strains of the virus that causes Ebola hemorrhagic fever has been engineered by scientists. The findings, made in mice, are a significant step toward immunotherapies that are effective against all strains of Ebola virus that cause human disease.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment